Gene Query: AIM2

Dataset Description Geneva Score
Transcriptional profiles of normal human mature B cells 32.33
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 26.98
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 26.98
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 25.14
Macrophage Ad5f35 M2 Challenge 24.18
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 23.16
Effects of rFVIIIFc on human macrophages 18.92
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 18.72
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 18.72
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 18.23
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 17.6
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 17.24
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 16.1
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 16.1
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 16.04
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 16.04
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 14.75
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 14.75
Transcriptome Profiling of Human Primary Monocytes 14.1
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 13.55
Widespread intronic polyadenylation diversifies immune cell transcriptomes 13.47
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 12.87
Characterization of parental and rociletinib-resistant derived H1975 cell lines 12.86
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 11.78
GATA3-mediated chromatin reprogramming in breast cancer cells 11.45
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 10.63
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 10.19
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 9.5
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 9.5
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 9.32
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 9.12
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 9.06
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 8.65
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 8.38
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 8.28
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 7.72
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 7.5
Macrophage Ad5f35 PhenoMap 7.49
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 7.39
Gene expression profile of multiple myeloma cell lines treated with CB-5083 7.17
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 6.91
Integrin signaling regulates YAP/TAZ to control skin homeostasis 6.51
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 6.42
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 6.18
Transcriptome of diurnal human blood neutrophils 6.11
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 6.02
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 6.01
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 5.93
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 5.83
Ro60-knockout cells 5.49
The Genetic Landscape of Diamond-Blackfan Anemia 5.3
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 5.27
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 5.24
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 5.22
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 5.07
Expression profiles of the four human major ectodermal lineages 5.01
RNA-seq of tumor cells following angiopellosis extravasation 4.92
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 4.86
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 4.74
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 4.73
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 4.7
oxLDL exposed trained monocytes 4.57
Transcriptomes of oxLDL exposed trained monocytes 4.57
Transcriptomes of human monocytes after ex vivo exposure to uric acid 4.47
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 4.44
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 4.44
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 4.4
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 4.38
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 4.32
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 4.29
BACH2 in human plasma cell fate decision 4.23
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 4.21
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 4.17
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 4.06
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 4.05
Polarized B -cell functions 4.03
Seletive inhibition of CDK9 in DLBCL cell lines 3.97
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 3.94
JAK dependent survival of ALK- ALCL 3.84
Be1 and Be2 B cells are transcriptionally distinct 3.8
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 3.67
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 3.65
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 3.62
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 3.6
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 3.59
The cytokine environment influence on human skin-derived T cells 3.54
The evolution of N6-methyladenosine in primates 3.52
Transcriptomic analysis of human tonsillar TFH subsets 3.51
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 3.5
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 3.5
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 3.49
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 3.49
RNA sequencing of matched nephrectomy samples [RNA-seq] 3.49
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 3.42
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 3.34
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 3.3
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 3.3
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 3.3
MicroRNA-125a-5p overexpression in human macrophages 3.27
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 3.27
The role of FAM46C in myeloma cells [sequencing] 3.26
The role of FAM46C in myeloma cells 3.26
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 3.16
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 3.16
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 3.13
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 3.11
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 3.04
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 3.02
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 2.97
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 2.97
The Genomic Landscape of Atypical Fibroxanthoma 2.96
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.95
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 2.92
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 2.92
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 2.75
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 2.75
MHC Transcriptomic landscape at haplotype-specific resolution 2.74
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 2.69
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 2.62
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 2.57
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 2.54
Transcriptional changes in lymphoma cells induced by LSD1 depletion 2.54
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 2.54
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 2.52
Human Treg IFNg/IL-10 subpopulations 2.52
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 2.52
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 2.52
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 2.52
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 2.46
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 2.41
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 2.41
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 2.39
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 2.39
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 2.35
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 2.34
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 2.34
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 2.31
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 2.31
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 2.23
Transcriptome analysis of U87 cells upon LINC00152 knockdown 2.21
Transcriptional profile in human S. haematobium infection 2.1
A single cell reference map for human blood and tissue T cell activation 2.09
Bone marrow derived human B cells [normal proB] 2.07
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 2.07
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 2.07
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 2.07
Transcriptional effect of ETV1 knockdown in melanoma cells 2.05
NAPRT activation of macrophages 2.03
Human Treg NaCl stimulation 2.02
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 1.95
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 1.95
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 1.94
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 1.93
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 1.89
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 1.85
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 1.83
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 1.83
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 1.83
Hepatosplenic T cell lymphoma 1.83
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 1.83
RNA-seq of resting and activated CD4+ T cells +-JQ1 1.8
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 1.76
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 1.75
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 1.75
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 1.74
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 1.72
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 1.68
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 1.67
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 1.67
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 1.66
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 1.66
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 1.63
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 1.62
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 1.62
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.6
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 1.6
Human Treg IL-12 stimulation 1.58
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 1.56
Expression level comparison under dividing and quiescent states in human primary fibroblasts 1.56
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 1.55
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 1.55
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 1.5
Effect of PRDM11 depletion in U2932 cells 1.5
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 1.5
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 1.5
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.49
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 1.47
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 1.47
Total RNA-Seq data from leukemic patients with complex structural variants 1.45
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 1.43
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 1.42
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 1.42
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 1.41
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 1.4
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.39
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 1.38
RIG-I and MDA5 fRIP during KSHV lytic reactivation 1.38
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 1.37
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 1.36
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 1.32
Persistence of stem cell metabolism in cancers as a failure of differentiation 1.32
Gene expression activation in CLL mediated by MSCs contact 1.32
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 1.31
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 1.29
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 1.29
Transcriptome of activated human and mouse MAIT cells 1.29
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 1.28
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 1.24
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 1.22
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 1.22
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 1.21
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 1.21
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 1.19
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 1.19
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 1.15
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 1.14
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 1.13
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 1.11
Non-coding regions are the main source of tumor-specific antigens 1.11
Non-coding regions are the main source of tumor-specific antigens [human] 1.11
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 1.1
Trans-differentiation of human adult peripheral blood T cells into neurons 1.1
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 1.09
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 1.09
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 1.09
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 1.09
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 1.08
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 1.05
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 1.05
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 1.04
MeRIP-seq for heat shock in B-cell lymphoma cells 1.03
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.02
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 1.02
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 1.01
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 1.0
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 0.96
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 0.94
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.93
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.93
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 0.93
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 0.93
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 0.92
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 0.92
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 0.92
Mutational landscape of splicing genes and functional consequences across 33 cancer types 0.91
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.91
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 0.89
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 0.89
Gene expression of thyroid cancer cell lines 0.88
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 0.87
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.86
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 0.85
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 0.85
Transcriptome wide analysis of classically and alternatively activated macrophages 0.83
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 0.82
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 0.81
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 0.79
Identification of global regulators of T-helper cell lineage specification 0.79
CircRNAome diversity in human mature B-cells, T-cells and monocytes 0.78
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.78
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 0.76
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 0.75
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 0.74
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 0.73
A practical evaluation of alignment algorithms for RNA variant calling analysis 0.71
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 0.71
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 0.7
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.7
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 0.69
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 0.69
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 0.69
Effect of Hotair overexpression in human breast cancer cell lines 0.68
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 0.68
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 0.68
CD74 role in transcription regulation [RNA-seq] 0.68
CD74 role in transcription regulation 0.68
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 0.68
DAOY-Notch1/Notch2 knockout: transcriptome comparison 0.67
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 0.65
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 0.63
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 0.63
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 0.63
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.62
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 0.62
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 0.62
Generation and functional characterization of MDSC-like cells 0.61
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 0.61
The expression profiles of GBC liver metastasis 0.6
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 0.6
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 0.6
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 0.6
The Human Testis Cell Atlas via Single-cell RNA-seq 0.6
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 0.59
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 0.59
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 0.59
The pause-initiation limit restricts transcription activation in human cells 0.59
Landscape and variation of RNA secondary structure across the human transcriptome 0.59
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 0.59
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 0.58
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 0.58
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 0.58
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 0.57
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 0.57
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 0.56
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 0.55
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 0.54
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 0.54
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 0.54
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.54
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 0.53
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 0.53
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.52
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 0.52
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.51
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 0.51
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 0.51
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 0.5
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 0.5
Genome wide expression change by RNF168 knocking down in NEC cells 0.5
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 0.49
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 0.48
Transcriptomic analysis of human macrophages in 3D 0.48
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 0.48
Integrating single-cell transcriptomic data across different conditions, technologies, and species 0.48
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 0.46
Primate transcript and protein expression levels evolve under compensatory selection pressures 0.46
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.46
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.45
Global analysis of alternative splicing regulated by RBM10 0.45
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 0.44
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 0.44
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 0.44
Analysis of transcriptional regulation by Myt1 and Myt1l 0.43
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 0.42
RNA editing in nascent RNA affects pre-mRNA splicing 0.42
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 0.41
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 0.41
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 0.4
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 0.4
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 0.4
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 0.4
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 0.39
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 0.39
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 0.38
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 0.38
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 0.37
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 0.37
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.37
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.37
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 0.37
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.37
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 0.36
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 0.36
Microglia innatly develop within cerebral organoids 0.36
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 0.36
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 0.35
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 0.34
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.34
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 0.32
RNA-Seq in PWS iPSC-derived neurons 0.32
CROP-Seq in Primary Human T Cells 0.32
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 0.32
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 0.32
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 0.32
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 0.32
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 0.31
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 0.31
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 0.3
RNA-seq analysis and shRNA screen of breast cancer 0.3
RNA-seq analysis of breast cancer 0.3
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 0.29
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 0.29
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.29
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.29
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.29
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 0.28
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.28
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.28
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 0.27
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.27
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 0.27
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 0.26
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.26
RNA-Seq and expression data from human adipose tissue 0.26
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 0.26
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 0.26
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 0.26
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.26
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.26
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 0.25
HEXIM1 is induced by DHODH inhibition to suppress melanoma 0.25
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 0.25
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 0.25
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.25
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.25
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 0.25
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 0.25
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.24
CHD1 regulates cell fate determination by activation of differentiation-induced genes 0.24
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 0.23
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.23
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.23
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.23
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.23
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 0.22
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 0.22
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 0.22
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 0.22
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 0.22
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.22
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 0.22
The comparison of high-throughput single-cell RNA-seq methods 0.21
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 0.21
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.2
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.2
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.2
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.19
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.19
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.19
Measure transcript integrity using RNA-seq data 0.19
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 0.18
RNA-seq of MCF10A cells and CAF 0.18
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.18
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 0.17
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.17
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.17
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 0.17
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 0.17
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 0.17
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 0.16
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.16
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 0.16
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 0.16
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 0.16
Global response to chemotherapy-induced apoptosis 0.16
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 0.16
Stem and effector CD8 T-cells from human cancers 0.16
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.15
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.15
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 0.15
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 0.14
RNA-Seq in neutrophils from Antiphospholipid Syndrome 0.14
RNA-seq data 0.14
ML29755 RNA-seq data 0.14
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 0.13
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.13
mRNA sequencing of oropharyngeal cancer cell lines 0.13
Single cell transcriptome of peritoneal cells 0.13
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.13
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 0.13
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 0.13
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 0.12
Landscape of H3K4me3 in human CD19 cells 0.12
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 0.11
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.11
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 0.1
MAIT cell RNA sequencing 0.1
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 0.1
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 0.1
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 0.1
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.09
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 0.09
quanTIseq: quantifying immune contexture of human tumors 0.09
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.09
The DNA methylation landscape of human melanoma [RNA-Seq] 0.08
The DNA methylation landscape of human melanoma 0.08
A novel target of EZH1/2 for treatment of mantle cell lymphoma 0.08
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 0.08
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 0.08
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.08
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.08
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.07
Aging-associated patterns in the expression of human endogenous retroviruses 0.07
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 0.07
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 0.07
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 0.07
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 0.07
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.07
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.06
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.06
Gene expression profiling in metabolically heterogeneous human lung tumors 0.06
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.06
LncRNA expression profiling of ischemic stroke patients 0.06
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.06
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 0.06
Expression analysis of the TAF1 syndrome 0.05
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.05
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 0.05
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.04
Reprogrammed myeloid cell transcriptomes in NSCLC 0.04
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 0.04
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 0.02
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 0.02
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 0.02
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.02
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.02
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.01
Tpl-2 and MEK small molecule inhibitors 0.01
Tpl-2 small molecule project 0.01
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation